Claude designs protein binders for 14 out of 15 targets successfully
TinfoilTricorn · x · 2026-08-19
Anthropic announced that Claude has successfully achieved de novo protein design. Guided by a human-written prompt, Claude autonomously designed protein binders for 14 out of 15 targets.
The company partnered with Adaptyv Bio and Twist Bioscience to independently synthesize and test these designs, verifying that the AI-generated molecules effectively bind to their targets. This breakthrough could significantly shorten the drug discovery timeline, which traditionally takes weeks or months of expert work per target.
Related event: Anthropic Says Claude Designed Protein Binders for 14 of 15 Targets(45 posts)→
More from Research
- LMR-BENCH at EMNLP 2025 tests whether LLM agents can reproduce real LLM research — ZhiyuChen4 · 2026-10-16
- Ex-OpenAI researcher claims most neurons are legible now; critics call it hype — anshulkundaje · 2026-10-16
- Physicist pushes back on ML community's acceptance that models may be beyond understanding — tszzl · 2026-10-16
- Survey: AI agent evaluation is getting realistic but still fails to measure safety and reliability — burkov · 2026-10-16
- COVA-SFT dataset trains models to solve text problems with visual chain-of-thought — yoavartzi · 2026-10-16
- USTC paper uses speculative sampling to cut latency in interactive video generation — ustc · 2026-10-16